| 股票代码：600272 | 股票简称：开开实业 | | | 编号：2026—001 | | --- | --- | --- | --- | --- | | 900943 | | 开开 | B 股 | | 上海开开实业股份有限公司 关于转让南京天石软件技术有限公司 11.11%股权的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 上海开开实业股份有限公司（以下简称"公司"）已经通过上海联 合产权交易所以公开挂牌转让的方式将所持有的南京天石软件技术有限 公司（以下简称"南京天石"）11.11%股权进行转让，挂牌价格为人民币 1,747.31 万元。挂牌期间共征集到一个合格意向受让方：南京众恒电气 有限公司，交易价格为人民币 1748.00 万元。公司于近日与受让方签订 了《上海市产权交易合同》。 本次交易不构成关联交易。 本次交易不构成重大资产重组。 本次交易已经公司第十届董事会第二十七次会议审议通过，无需 提交公司股东会审议，交易实施不存在重大法律障碍。 一、交易概述 经上海开开实业股份有限公司 ...

Market Overview - The pharmaceutical commercial sector increased by 0.79% compared to the previous trading day, with Luyuan Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 4082.98, down 0.07%, while the Shenzhen Component Index closed at 13959.48, down 0.51% [1] Top Gainers in Pharmaceutical Sector - Luyuan Pharmaceutical (002788) closed at 27.49, up 10.00% with a trading volume of 812,100 shares and a transaction value of 2.156 billion [1] - Saili Medical (603716) closed at 26.66, up 9.98% with a trading volume of 700,200 shares and a transaction value of 1.802 billion [1] - Dajia Weikang (301126) closed at 13.50, up 5.47% with a trading volume of 184,200 shares and a transaction value of 245 million [1] Other Notable Stocks - Run Da Medical (603108) closed at 16.31, up 5.23% with a trading volume of 378,400 shares and a transaction value of 614 million [1] - Huaren Health (301408) closed at 20.16, up 3.38% with a trading volume of 503,400 shares and a transaction value of 1.016 billion [1] Market Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 94.4079 million from institutional investors, while retail investors saw a net inflow of 213 million [2] - The overall market showed a mixed trend with some stocks experiencing significant outflows from institutional and speculative funds [2] Individual Stock Fund Flow - Saili Medical (603716) had a net inflow of 304 million from institutional investors, but a net outflow of 108 million from speculative funds [3] - Run Da Medical (603108) saw a net inflow of 62.5499 million from institutional investors, while experiencing outflows from both speculative and retail investors [3] - Huaren Health (301408) had a net inflow of 41.8956 million from institutional investors, but a significant outflow of 64.016 million from retail investors [3]

机构持仓方面，截止2025年9月30日，开开实业十大流通股东中，招商证券(香港)有限公司位居第三大 流通股东，持股113.11万股，持股数量较上期不变。BOCI SECURITIES LIMITED位居第七大流通股 东，持股86.27万股，持股数量较上期不变。中证上海国企ETF（510810）位居第八大流通股东，持股 78.75万股，相比上期减少16.42万股。 资料显示，上海开开实业股份有限公司位于上海市静安区昌平路678号一楼，成立日期1997年8月4日， 上市日期2001年2月28日，公司主营业务涉及以中医药流通、中医药学服务(中医问诊服务)和服装批 发、零售为主营业务。主营业务收入构成为：批发类74.48%，零售类18.18%，卫生服务类4.42%，租赁 类1.77%，其他1.14%。 开开实业所属申万行业为：医药生物-医药商业-医药流通。所属概念板块包括：医药电商、中药、生物 医药、首发经济、SPD概念等。 截至9月30日，开开实业股东户数3.37万，较上期减少7.03%；人均流通股0股，较上期增加0.00%。2025 年1月-9月，开开实业实现营业收入8.25亿元，同比增长10.76%；归母净利润 ...

股票代码：600272 股票简称： 开开实业 编号：2025—078 900943 开开 B 股 上海开开实业股份有限公司 关于使用闲置自有资金购买银行理财产品的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 委托理财受托方：兴业银行股份有限公司上海闸北支行（以下简称： "兴业银行"）； 委托理财金额：人民币3,000万元； 委托理财产品类型：结构性存款； 委托理财期限：178天； 履行的审议程序：2025年4月28日上海开开实业股份有限公司（以下 简称："公司"）召开第十届董事会第二十五次会议，以9票同意、0票反对、 0票弃权的表决结果，审议通过了《关于董事会授权购买低风险理财产品的 议案》，授权公司总经理室在2025年4月至2026年4月期间，阶段性的继续 利用短期闲置资金总金额不超过人民币1.8亿元，购买低风险理财产品。在 上述额度内资金可以滚动使用。在资金额度的使用期限内任一时点的交易 金额（含前述投资的收益进行再投资的相关金额）不超过该投资额度。本 议案无需提交股东大会审议。 特别风险提示：公司 ...

Group 1 - The stock of Shuyu Pingmin has dropped over 18% [1] - Other companies such as Renmin Tongtai, Dajia Weikang, Yingte Group, and Yao Yigou have all seen declines of over 5% [1] - Additional companies including Huaren Health, Zhongyao Holdings, and Kaikai Industrial have also experienced declines [1]

Core Viewpoint - The company is focused on developing its main business and aims to enhance both market and intrinsic value through various strategies, including governance improvement and innovation [1] Group 1: Business Strategy - The company has been actively expanding into the health industry and developing regional SPD business [1] - The company is exploring new opportunities in the dental sector with the launch of the Lei Yun Shang dental project [1] - The company is implementing comprehensive reforms in its apparel segment to release subsequent benefits [1] Group 2: Financial Outlook - The company acknowledges that the development of its transformation business requires ongoing cultivation and gradual growth [1] - Short-term operational performance may not reflect the company's efforts and could negatively impact profits [1]

12月19日，开开实业盘中下跌2.02%，截至09:38，报14.56元/股，成交3795.85万元，换手率1.62%，总 市值38.24亿元。 开开实业所属申万行业为：医药生物-医药商业-医药流通。所属概念板块包括：SPD概念、首发经济、 中药、医药电商、小盘等。 截至9月30日，开开实业股东户数3.37万，较上期减少7.03%；人均流通股0股，较上期增加0.00%。2025 年1月-9月，开开实业实现营业收入8.25亿元，同比增长10.76%；归母净利润1286.78万元，同比减少 62.81%。 分红方面，开开实业A股上市后累计派现1.91亿元。近三年，累计派现3474.90万元。 机构持仓方面，截止2025年9月30日，开开实业十大流通股东中，招商证券(香港)有限公司位居第三大 流通股东，持股113.11万股，持股数量较上期不变。BOCI SECURITIES LIMITED位居第七大流通股 东，持股86.27万股，持股数量较上期不变。中证上海国企ETF（510810）位居第八大流通股东，持股 78.75万股，相比上期减少16.42万股。 责任编辑：小浪快报 资金流向方面，主力资金净流入227.34万 ...

Group 1 - The core point of the article highlights the performance of Shanghai Kaikai Industrial Co., Ltd., which saw a stock price increase of 6.36%, reaching 15.04 CNY per share, with a trading volume of 1.23 billion CNY and a turnover rate of 5.28%, resulting in a total market capitalization of 39.50 billion CNY [1] - The company, established on August 4, 1997, and listed on February 28, 2001, primarily engages in traditional Chinese medicine distribution, Chinese medicine services (consultation services), and clothing wholesale and retail [1] - The revenue composition of the company's main business includes wholesale at 74.48%, retail at 18.18%, health services at 4.42%, leasing at 1.77%, and others at 1.14% [1] Group 2 - From the perspective of the top ten circulating shareholders, a fund under Huatai-PineBridge ranked among the top shareholders of Kaikai Industrial, while the China Securities Shanghai State-owned Enterprise ETF (510810) reduced its holdings by 164,200 shares, now holding 787,500 shares, which accounts for 0.33% of circulating shares [2] - The China Securities Shanghai State-owned Enterprise ETF (510810) was established on July 28, 2016, with a latest scale of 7.994 billion CNY, and has achieved a year-to-date return of 6.03%, ranking 3694 out of 4197 in its category [2]

Core Points - Shanghai Kaikai Industrial Co., Ltd. has completed the registration capital change and obtained a new business license [1] - The company issued 19,651,945 A-shares, increasing total shares from 243,000,000 to 262,651,945 [1] - The registered capital has been updated from RMB 243,000,000 to RMB 262,651,945 [1] Company Information - The company was established on August 4, 1997, and is located at 921 New Zha Road, Room 201, Jing'an District, Shanghai [1] - The legal representative is Zhuang Qianyun, and the company operates as a limited company with investments from Hong Kong, Macau, and Taiwan [1] - The business scope includes the production and sale of various textile products, clothing, and household items, as well as property leasing [1]

| 股票代码：600272 | 股票简称：开开实业 | | | 编号：2025—077 | | --- | --- | --- | --- | --- | | 900943 | | 开开 | B 股 | | 上海开开实业股份有限公司 关于完成注册资本变更登记并换发营业执照的公告 法定代表人：庄虔贇 注册资本：人民币26265.1945万元整 成立日期：1997年08月04日 住所：上海市静安区新闸路921号201室K02 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 上海开开实业股份有限公司（以下简称"公司"）于2025年10月29日召 开第十届董事会第二十九次会议，审议通过了《关于变更公司注册资本、 取消监事会并修订<公司章程>部分条款的议案》。公司已于2025年7月15 日完成向特定对象发行A股股票相关工作，共计发行A股股票19,651,945 股。因此，公司股份总数由243,000,000股变更为262,651,945股，公司注 册资本由人民币243,000,000元变更为人民币262,651,945元。上述变更注 ...